NHS Rolls Out Abiraterone: Halves Prostate Death Risk
NHS England will roll out the affordable prostate cancer drug abiraterone to thousands of high-risk patients, following landmark ICR research showing two years of treatment halves relapse risk and significantly cuts early death rates.
Trending Videos
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)